NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 5 நாட்களுக்கு முன்இன்று 56 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Heranba Appoints Rajib Mukhopadhyay as Chief Financial Officer Effective January 1, 2027
Heranba Industries has appointed Mr. Rajib Mukhopadhyay as its Chief Financial Officer and Key Managerial Personnel, effective January 1, 2027. Mr. Mukhopadhyay brings over 20 years of leadership experience across finance domains, having previously served as CFO at Sutlej Textiles and Indofil Industries Limited. The appointment comes at a crucial juncture as Heranba navigates operational turnaround following a TTM net loss of ₹77 Cr and net debt of ₹482 Cr amid global agrochemical sector headwinds.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. Rajib Mukhopadhyay has been appointed as CFO and KMP of Heranba Industries, effective January 1, 2027.
ஏன் இது முக்கியம்A leadership addition in the finance function with relevant agrochemical industry background (ex-Indofil) is notable as the company manages elevated debt (₹482 Cr) and works to turn around recent losses (TTM net loss of ₹77 Cr).
Effective date of appointment: ஜனவரி 01, 2027Professional finance experience: more than 20 yearsCompany TTM Revenue: ₹1525 கோடிCompany Total Debt: ₹482 கோடி
📅 குறுகிய காலம்Limited immediate stock price impact; the new CFO assumes charge on January 1, 2027.
📈 நீண்ட காலம்His expertise in fundraising, treasury, and business restructuring will be relevant to managing debt levels, cost structures, and working capital as new production facilities scale up.
👀 கவனிக்க வேண்டியவை
Track the transition process leading up to January 1, 2027, and observe forthcoming quarterly disclosures for updates on balance sheet deleveraging and capital allocation strategies.
Heranba Q2 FY27 Consol Revenue Down 28.7% YoY to ₹372.09 Cr; Appoints New CFO
Heranba Industries reported consolidated segment revenue of ₹372.09 crore for Q2 FY27 (quarter ended September 30, 2026), down 28.7% YoY from ₹521.71 crore in Q2 FY26. Standalone revenue fell 45.1% YoY to ₹332.59 crore, while standalone net profit declined 15.5% YoY to ₹27.09 crore compared to ₹32.04 crore in the prior-year period. Export segment share contracted to 21.98% of consolidated revenue versus 26.96% in Q2 FY26, reflecting persistent international agrochemical headwinds. Additionally, the Board approved the appointment of Mr. Rajib Mukhopadhyay as Chief Financial Officer effective January 01, 2027.
உச்சம் நம்பிக்கை
என்ன மாறியதுHeranba reported Q2 FY27 financial results showing sharp YoY top-line contraction and appointed Rajib Mukhopadhyay as the incoming CFO.
ஏன் இது முக்கியம்Top-line declines highlight sustained volume and pricing pressure across export markets, dampening the revenue base across both standalone and consolidated operations.
📅 குறுகிய காலம்The continued YoY drop in top-line performance and weak export contributions are likely to keep sentiment subdued in the near term.
📈 நீண்ட காலம்Structural turnaround depends on resolving global agrochemical channel inventory destocking and realizing operating leverage from new capex assets.
⚠ அபாய எச்சரிக்கைகள்
Export revenue contraction (-41.9% YoY in Q2)
Underutilization risk on newly added capital assets
👀 கவனிக்க வேண்டியவை
Track recovery in export realizations and capacity utilization of recently expanded manufacturing facilities at Saykha and Sarigam in upcoming quarters.
Heranba CFO Pravin Shetty Resigns Effective December 31, 2026
Heranba Industries has announced that its Chief Financial Officer (CFO) and Key Managerial Personnel, Mr. Pravin Shetty, has tendered his resignation effective December 31, 2026, citing personal and family commitments. In his resignation letter, he noted that he served for 12 months and is concluding key assignments, including a consortium funding exercise. The company reported a net loss of Rs 77.26 Cr in FY26 against a market cap of Rs 597 Cr, making finance leadership transition critical. The company will initiate the process to appoint a replacement within statutory timelines.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. Pravin Shetty has resigned as Chief Financial Officer and Key Managerial Personnel of Heranba Industries.
ஏன் இது முக்கியம்A CFO exit within 12 months introduces leadership instability at a time when the company carries Rs 482 Cr in debt and is finalizing consortium funding amid negative TTM profitability.
Resignation tender date: அக்டோபர் 26, 2026Effective cessation date: டிசம்பர் 31, 2026CFO tenure length: 12 மாதங்கள்Total Debt vs Net Worth (Context): 0.49x (Rs 482 Cr / Rs 974 Cr)
📅 குறுகிய காலம்Short-term sentiment could remain subdued given the short 12-month tenure of the departing CFO during an ongoing consortium funding process.
📈 நீண்ட காலம்Limited operational disruption provided a capable successor is appointed smoothly before the December 31, 2026 transition date.
⚠ அபாய எச்சரிக்கைகள்
Short CFO tenure of just 12 months
Pending closure of consortium funding exercise during management transition
👀 கவனிக்க வேண்டியவை
Track the appointment of a new CFO and updates on the closure of the consortium funding exercise, given the company's Rs 482 Cr debt load.
Heranba Approves Up to ₹25 Cr Capital Infusion in Subsidiary Mikusu India via Rights Issue
Heranba Industries' Board of Directors approved an additional investment of up to ₹25 Crore in its wholly owned subsidiary, Mikusu India Private Limited, via a rights issue. Mikusu India, engaged in trading agrochemical products, reported a turnover of ₹182.68 Crore in FY26, up from ₹152.40 Crore in FY25 and ₹92.91 Crore in FY24. The capital infusion represents ~3.7% of Heranba's current market capitalization (₹668 Crore) and is intended to support Mikusu's operational and growth needs without changing the 100% shareholding structure.
உச்சம் நம்பிக்கை
என்ன மாறியதுHeranba is injecting up to ₹25 Crore of fresh equity into its wholly owned trading arm, Mikusu India.
ஏன் இது முக்கியம்Provides working capital to support Mikusu India's expanding trading operations, which have scaled from ₹92.91 Crore to ₹182.68 Crore turnover over the last two fiscal years.
📅 குறுகிய காலம்Neutral impact as the transaction is an internal capital reallocation between the parent and its 100% subsidiary.
📈 நீண்ட காலம்Supports growth in the agrochemical trading vertical, though overall consolidated profitability remains reliant on core technicals and manufacturing asset utilization.
⚠ அபாய எச்சரிக்கைகள்
Consolidated working capital strain given Heranba's net loss in FY26 and existing debt of ₹482 Cr.
👀 கவனிக்க வேண்டியவை
Track the deployment timeline of the ₹25 Crore infusion and monitor if Mikusu's trading volume growth improves consolidated operating margins in subsequent quarterly results.
Heranba Q1 Standalone PAT at ₹9.46 Cr (Down 57% YoY); Approves ₹25 Cr Subsidiary Infusion
Heranba Industries reported standalone revenue of ₹364.99 crore for the quarter ended June 30, 2026, declining 25.5% YoY from ₹489.84 crore but recovering 3.3% QoQ. Standalone PAT fell 57.0% YoY to ₹9.46 crore compared to ₹22.02 crore in Q1 FY26, though it rebounded into profit from a net loss of ₹12.50 crore in Q4 FY26. Diluted EPS stood at ₹2.37 versus ₹5.50 YoY. Additionally, the Board approved an equity investment of up to ₹25 crore in its wholly owned subsidiary, Mikusu India Private Limited, through a rights issue.
உச்சம் நம்பிக்கை
என்ன மாறியதுReported Q1 standalone results marking a sequential return to profitability despite YoY contraction, and approved a ₹25 crore capital infusion in subsidiary Mikusu India.
ஏன் இது முக்கியம்Shows operational stabilization after Q4 FY26 losses, though ongoing global agrochemical pricing and volume pressures continue to keep margins compressed relative to historic levels.
Revenue from Operations (Q1): ₹364.99 கோடிNet Profit (Q1): ₹9.46 கோடிSubsidiary Investment: ₹25.00 கோடிInvestment vs Net Worth: ~2.6%
📅 குறுகிய காலம்Sequential profit recovery from Q4 losses may offer near-term relief, though the substantial YoY decline reflects persistent sector-wide headwinds.
📈 நீண்ட காலம்Long-term recovery relies on demand stabilization in export technicals, operating leverage from recently commissioned capex, and commercial execution in subsidiaries.
⚠ அபாய எச்சரிக்கைகள்
Continued pricing and demand pressure in the agrochemical export technicals segment
Asset underutilization impacting returns on recent capex additions
👀 கவனிக்க வேண்டியவை
Track capacity ramp-up and export realization trends across the Saykha and Sarigam plants, alongside deployment and return metrics from the ₹25 crore subsidiary investment.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Heranba Settles IBC Dispute; NCLT Allows Withdrawal of Insolvency Application
Heranba Industries has successfully settled its dispute with Haresh Petrochem Private Limited, which had previously filed an insolvency application under Section 9 of the IBC. The National Company Law Tribunal (NCLT), Ahmedabad, passed an order on June 08, 2026, allowing the withdrawal of the application following the settlement. As a result, no Corporate Insolvency Resolution Process (CIRP) has been initiated against the company. This resolution eliminates a significant legal risk that could have impacted the company's operations and credit standing.
முக்கிய அம்சங்கள்
NCLT Ahmedabad permitted the withdrawal of the Section 9 IBC application filed by Haresh Petrochem Private Limited.The matter was settled out of court between Heranba Industries and the applicant.No Corporate Insolvency Resolution Process (CIRP) was initiated against the company.The final order disposing of the application was dated June 08, 2026.The company confirmed there is no material adverse impact on its operations following this order.
👀 கவனிக்க வேண்டியவை
Investors can breathe a sigh of relief as the threat of insolvency proceedings has been removed. Continue to monitor the company's cash flow management to ensure no further payment defaults occur.
Heranba FY26 Revenue Up 17% to ₹1,756 Cr; Q4 Net Loss Widens to ₹12.5 Cr
Heranba Industries reported a mixed set of results for FY26, with annual revenue growing 17.4% YoY to ₹1,755.55 crore, though annual net profit declined by 5.8% to ₹50.87 crore. The fourth quarter (Q4FY26) was particularly weak, with revenue falling 10.6% YoY and net losses widening to ₹12.50 crore from a loss of ₹5.28 crore in the previous year's quarter. Financial health concerns have emerged as short-term borrowings doubled to ₹458.05 crore and operating cash flow turned significantly negative at ₹(203.92) crore. Consequently, the board has skipped recommending a dividend for the year.
முக்கிய அம்சங்கள்
Full-year FY26 revenue increased 17.4% YoY to ₹1,755.55 crore, but Net Profit fell 5.8% to ₹50.87 crore.Q4 FY26 standalone net loss widened to ₹12.50 crore compared to a loss of ₹5.28 crore in Q4 FY25.Short-term borrowings surged to ₹458.05 crore as of March 31, 2026, up from ₹230.46 crore in the previous year.Net cash flow from operating activities deteriorated to negative ₹203.92 crore from a positive ₹136.71 crore in FY25.The Board of Directors did not recommend any dividend for the financial year 2025-26.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company faces margin pressure from rising raw material costs and a significant increase in debt. The transition to negative operating cash flow and the decision to skip dividends suggest liquidity tightness that warrants close monitoring.
Heranba Shareholders Approve Director Appointments with 99.99% Majority
Heranba Industries Limited has successfully passed two special resolutions via postal ballot with near-unanimous shareholder support. The resolutions involved the appointment of Mr. Omprakash Singh as a Non-Executive Independent Director for five years and Mr. Roshan R Shetty as a Whole Time Director. The voting saw a total turnout of 75.24% of outstanding shares, with both resolutions receiving 99.99% approval from the voting members. This indicates strong alignment between the management and the shareholder base, including promoters and public institutions.
முக்கிய அம்சங்கள்
Appointment of Mr. Omprakash Singh as Independent Director approved with 30,105,046 votes in favor (99.99%).Appointment of Mr. Roshan R Shetty as Executive Director approved with 30,104,959 votes in favor (99.99%).Total voter turnout represented 75.24% of the company's total outstanding shares.Promoter and Promoter Group voted 100% in favor of both resolutions, representing 29,987,138 shares.The postal ballot process was conducted between April 22, 2026, and May 21, 2026.
👀 கவனிக்க வேண்டியவை
Investors should take note of the stable leadership and strong shareholder mandate, which supports management continuity. No immediate portfolio action is required as these are standard governance appointments.
NCLT Dismisses Insolvency Application Against Heranba Industries Subsidiary
The National Company Law Tribunal (NCLT), Mumbai Bench, has dismissed an insolvency application filed under Section 9 of the IBC against Heranba Organics Private Limited, a wholly-owned subsidiary of Heranba Industries. The application, filed by Haresh Petrochem Private Limited, was rejected because the principal operational debt fell below the mandatory threshold limit after excluding interest components. This ruling ensures that no Corporate Insolvency Resolution Process (CIRP) will be initiated against the subsidiary, removing a potential legal risk for the parent company.
முக்கிய அம்சங்கள்
NCLT Mumbai Bench-VI dismissed the Section 9 IBC application on May 12, 2026The application was filed by Haresh Petrochem Private Limited against wholly-owned subsidiary Heranba Organics Private LimitedDismissal was based on the debt falling below the threshold limit prescribed under Section 4 of the IBCNo Corporate Insolvency Resolution Process (CIRP) has been initiated against the subsidiaryCompany confirms no material adverse impact on Heranba Industries Limited following this order
👀 கவனிக்க வேண்டியவை
Investors can take comfort in the dismissal of this insolvency petition, which removes a legal overhang on the company's subsidiary. No further action is required as the operational risk from this specific litigation has been mitigated.
Heranba Converts ₹450 Cr Inter-Corporate Deposits into OFCDs in Subsidiary HOPL
Heranba Industries has completed the conversion of ₹450 crore worth of unsecured Inter-Corporate Deposits (ICDs) into Optionally Fully Convertible Debentures (OFCDs) in its wholly-owned subsidiary, Heranba Organics Private Limited (HOPL). This internal debt restructuring involves the allotment of 45 crore OFCDs at ₹10 each and does not involve any fresh cash outflow. The subsidiary, HOPL, has shown significant growth with a turnover of ₹220.58 crore in FY 2024-25 compared to just ₹0.27 crore in the previous year. The parent company continues to hold 100% equity and control in the subsidiary.
முக்கிய அம்சங்கள்
Conversion of ₹450 crore existing unsecured ICDs into 45,00,00,000 1% OFCDs at parSubsidiary HOPL reported a turnover of ₹220.58 crore for FY 2024-25, up from ₹0.27 crore in FY 2023-24The transaction is an internal debt restructuring with no fresh cash outflow from Heranba IndustriesHeranba Industries maintains 100% shareholding and control of HOPL post-conversionThe conversion was executed on an arm's length basis as per SEBI regulations
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine internal financial cleanup that formalizes the debt structure of the subsidiary. The rapid revenue growth in the HOPL subsidiary is a positive operational sign to monitor in future consolidated earnings.
Heranba Industries to Convert ₹450 Cr ICDs into OFCDs of Subsidiary Heranba Organics
Heranba Industries has approved the conversion of ₹450 crore in existing unsecured Inter-Corporate Deposits (ICDs) provided to its wholly-owned subsidiary, Heranba Organics Private Limited (HOPL), into Optionally Fully Convertible Debentures (OFCDs). This internal restructuring involves the issuance of 45 crore OFCDs at a face value of ₹10 each on a private placement basis. The transaction does not involve any fresh cash outflow and is designed to restructure the debt profile of the subsidiary. HOPL, which operates in the agrochemicals sector, showed significant growth with a turnover of ₹220.58 crore in FY 2024-25 compared to just ₹0.27 crore in the previous year.
முக்கிய அம்சங்கள்
Conversion of ₹450 crore unsecured ICDs into 45,00,00,000 OFCDs at a face value of ₹10 eachTarget entity Heranba Organics Private Limited (HOPL) is a 100% material unlisted subsidiaryHOPL reported a substantial turnover increase to ₹220.58 crore in FY 2024-25 from ₹0.27 crore in FY 2023-24The restructuring involves no fresh cash outflow and maintains 100% parent controlThe transaction was conducted on an arm's-length basis as part of internal debt management
👀 கவனிக்க வேண்டியவை
As this is an internal financial restructuring with no cash outflow, it has no immediate impact on consolidated valuations. Investors should focus on the rapid scaling of the subsidiary HOPL as a potential future growth driver for the parent company.
Heranba Industries to Convert ₹450 Cr Subsidiary Loan into 10-Year Convertible Debentures
Heranba Industries has approved the conversion of ₹450 crore in Inter-Corporate Deposits (ICDs) provided to its wholly-owned subsidiary, Heranba Organics Private Limited, into Optionally Fully Convertible Debentures (OFCDs). This restructuring formalizes the internal funding into a long-term instrument with a 10-year tenure and a nominal 1% annual interest rate. The OFCDs provide the parent company the option to convert the debt into equity shares of the subsidiary in the future. Since this is an internal transaction between a parent and its 100% subsidiary, it has no immediate impact on consolidated financial performance.
முக்கிய அம்சங்கள்
Conversion of ₹450 crore existing Inter-Corporate Deposits into Optionally Fully Convertible Debentures (OFCDs).The new debentures carry a long-term tenure of 10 years.The coupon rate is set at a nominal 1% per annum, significantly lower than market debt rates.The transaction is aimed at restructuring existing inter-company funding on an arm's length basis.
👀 கவனிக்க வேண்டியவை
No immediate action is required as this is a balance sheet reclassification of existing internal funds. Investors should monitor the operational progress of the subsidiary, Heranba Organics, to evaluate the long-term value of the conversion option.
Heranba Launches New Crop Nutrition Products; Targets ₹2,500 Cr Revenue in FY26
Heranba Industries has strategically entered the high-growth crop nutrition segment with the launch of two new products, Fentaamine and MycoHil, developed in collaboration with an American MNC. The company has set an ambitious total revenue target of ₹2,500 crore for the current fiscal year, supported by its entry into this segment which is growing at a 15% CAGR. Expansion plans also include establishing a subsidiary in Dubai to penetrate Middle Eastern and African markets. This diversification leverages Heranba's seven manufacturing facilities and aims to move beyond its core synthetic pyrethroids business.
முக்கிய அம்சங்கள்
Launched Fentaamine (bio-stimulant) and MycoHil (bio-fertilizer) in collaboration with a leading American MNCSet an ambitious total revenue target of ₹2,500 crore for the current fiscal yearTargeting the crop nutrition segment which is growing at a CAGR of over 15% globally and in IndiaPlans to establish a subsidiary in Dubai to strengthen presence across 80+ countriesLeveraging 7 world-class manufacturing facilities to scale up CMO operations and brand equity
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to meet the ₹2,500 crore revenue guidance and the market's response to the new bio-stimulant products. The diversification into high-growth segments and global expansion via a Dubai subsidiary are strong positive indicators for long-term value.
Heranba Appoints Omprakash Singh and Roshan Shetty to Board for 5-Year Terms
Heranba Industries has announced the appointment of Mr. Omprakash S. Singh as a Non-Executive Independent Director and Mr. Roshan R. Shetty as an Executive Director, both for five-year terms starting April 1, 2026. Mr. Singh brings over 40 years of experience in legal, secretarial, and SEBI compliance matters. Mr. Roshan Shetty, a Chemical Engineer from Georgia Tech and son of the Managing Director, holds a 1.59% stake and will focus on process design and engineering. These appointments are subject to shareholder approval and aim to strengthen the company's governance and technical leadership.
முக்கிய அம்சங்கள்
Mr. Omprakash S. Singh appointed as Independent Director for a 5-year term with 40+ years of legal experience.Mr. Roshan R. Shetty appointed as Executive Director for a 5-year term starting April 2026.Mr. Roshan Shetty holds a 1.59% equity stake and is the son of the current Managing Director.New Executive Director brings technical expertise from Georgia Institute of Technology in Chemical Engineering.Appointments are aimed at improving operational efficiency and ensuring robust regulatory compliance.
👀 கவனிக்க வேண்டியவை
Investors should monitor if the technical expertise of the new Executive Director leads to improved R&D or operational margins. No immediate action is required as these are standard leadership transitions and succession planning.
Heranba Industries Faces ₹2.63 Crore Insolvency Petition Over Quality Dispute
Haresh Petrochem Private Limited has filed an insolvency application against Heranba Industries Limited under the IBC for a claim of approximately ₹2.63 Crores. Heranba has clarified that the payment was withheld due to quality issues with the goods supplied and is actively working to resolve the matter. The company expects to settle the dispute amicably outside of the NCLT proceedings. While the filing is a material event, the relatively small claim amount suggests it is a commercial dispute rather than a sign of systemic financial distress.
முக்கிய அம்சங்கள்
Insolvency petition filed under Section 9 of the IBC at NCLT Ahmedabad.Claim amount involved is approximately ₹2.63 Crores.Non-payment attributed to quality issues in goods/services provided by the petitioner.Next hearing date for the matter is scheduled for April 20, 2026.Management expects an out-of-court settlement with no long-term impact on operations.
👀 கவனிக்க வேண்டியவை
Investors should monitor the situation until the next hearing on April 20, 2026, to ensure a settlement is reached. Given the small claim size relative to Heranba's scale, this is likely a tactical legal move by a creditor rather than a solvency crisis.
IBC Insolvency Application Filed Against Heranba Subsidiary Over Rs 93.90 Lakh Claim
Haresh Petrochem Private Limited has filed an insolvency petition under the IBC against Heranba Organics Private Limited, a 100% subsidiary of Heranba Industries. The initial claim was approximately Rs 1.70 Crores, which has been reduced to an outstanding balance of Rs 93.90 Lakhs following part payments. The company states the remaining balance is withheld due to quality disputes regarding the supplied goods. Management expects to settle the matter amicably outside the NCLT framework once the quality issues are addressed.
முக்கிய அம்சங்கள்
Insolvency application filed under Section 9 of IBC against 100% subsidiary Heranba Organics.Total claim amount reduced from Rs 1.70 Crores to an outstanding balance of Rs 93.90 Lakhs.Payment withheld by the subsidiary due to unresolved quality issues with the petitioner's supplies.Management expects an out-of-court settlement and does not anticipate long-term material impact.
👀 கவனிக்க வேண்டியவை
Monitor the progress of the NCLT proceedings to ensure the settlement is reached as planned. While the claim amount is small, any escalation in insolvency proceedings for a subsidiary requires caution.
Heranba Q3: Consolidated Net Loss Widens to ₹23.29 Cr; Standalone Profit at ₹9.32 Cr
Heranba Industries reported a weak set of consolidated numbers for Q3 FY26, with the net loss widening to ₹23.29 crore from a loss of ₹10.37 crore in the same quarter last year. Consolidated revenue from operations declined to ₹305.17 crore, down from ₹341.29 crore year-on-year. While standalone operations turned profitable at ₹9.32 crore compared to a loss last year, the consolidated performance was dragged down by higher finance costs and depreciation. The company also announced the appointment of ZMAS and Associates as the new Internal Auditor.
முக்கிய அம்சங்கள்
Consolidated revenue from operations fell to ₹305.17 crore in Q3 FY26 from ₹341.29 crore in Q3 FY25.Consolidated net loss widened significantly to ₹23.29 crore versus a loss of ₹10.37 crore YoY.Standalone profit stood at ₹9.32 crore, a recovery from a standalone loss of ₹9.12 crore in the previous year's quarter.Consolidated finance costs doubled to ₹12.39 crore from ₹6.15 crore in the year-ago period.Consolidated depreciation and amortisation expenses rose sharply to ₹25.67 crore from ₹14.03 crore YoY.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as widening consolidated losses and rising finance costs indicate significant pressure on the bottom line. The divergence between standalone profit and consolidated loss suggests underperformance in subsidiary operations that requires further scrutiny.
Heranba Subsidiary to Incorporate UAE Unit with INR 2 Crore Initial Investment
Heranba Industries Limited has announced that its wholly-owned subsidiary, Mikusu India Private Limited, will establish a new 100% subsidiary in the United Arab Emirates. The new entity will focus on the agro-chemical business, specifically pesticides, insecticides, and herbicides. An initial cash investment of up to INR 2.00 crores is planned for this expansion. This strategic move aims to enhance the company's global footprint and distribution capabilities in the Middle East.
முக்கிய அம்சங்கள்
Board of Mikusu India Private Limited approved the 100% WOS in UAE on January 14, 2026.Proposed initial investment in the UAE subsidiary is up to INR 2.00 crores in cash.The entity will deal in chemical products including fungicides, weedicides, and pesticides.RBI approval will be required for the remittance of Outward Direct Investment (ODI) post-inception.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward international market penetration. Monitor the progress of the UAE subsidiary's incorporation and its eventual contribution to the company's export revenue.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
